BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ayoub MA, Zhang Y, Kelly RS, See HB, Johnstone EK, McCall EA, Williams JH, Kelly DJ, Pfleger KD. Functional interaction between angiotensin II receptor type 1 and chemokine (C-C motif) receptor 2 with implications for chronic kidney disease. PLoS One 2015;10:e0119803. [PMID: 25807547 DOI: 10.1371/journal.pone.0119803] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Yvinec R, Ayoub MA, De Pascali F, Crépieux P, Reiter E, Poupon A. Workflow Description to Dynamically Model β-Arrestin Signaling Networks. Methods Mol Biol 2019;1957:195-215. [PMID: 30919356 DOI: 10.1007/978-1-4939-9158-7_13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Sanchez J, Lane JR, Canals M, Stone MJ. Influence of Chemokine N-Terminal Modification on Biased Agonism at the Chemokine Receptor CCR1. Int J Mol Sci 2019;20:E2417. [PMID: 31096719 DOI: 10.3390/ijms20102417] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
3 Durdagi S, Erol I, Salmas RE, Aksoydan B, Kantarcioglu I. Oligomerization and cooperativity in GPCRs from the perspective of the angiotensin AT1 and dopamine D2 receptors. Neurosci Lett 2019;700:30-7. [PMID: 29684528 DOI: 10.1016/j.neulet.2018.04.028] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
4 Ayoub MA. Resonance Energy Transfer-Based Approaches to Study GPCRs. Methods Cell Biol 2016;132:255-92. [PMID: 26928548 DOI: 10.1016/bs.mcb.2015.10.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
5 Johnstone EK, Pfleger KD. Bioluminescence Resonance Energy Transfer Approaches to Discover Bias in GPCR Signaling. Methods Mol Biol 2015;1335:191-204. [PMID: 26260602 DOI: 10.1007/978-1-4939-2914-6_13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Fu Q, Colgan SP, Shelley CS. Hypoxia: The Force that Drives Chronic Kidney Disease. Clin Med Res 2016;14:15-39. [PMID: 26847481 DOI: 10.3121/cmr.2015.1282] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 12.2] [Reference Citation Analysis]
7 Huma ZE, Sanchez J, Lim HD, Bridgford JL, Huang C, Parker BJ, Pazhamalil JG, Porebski BT, Pfleger KDG, Lane JR, Canals M, Stone MJ. Key determinants of selective binding and activation by the monocyte chemoattractant proteins at the chemokine receptor CCR2. Sci Signal 2017;10:eaai8529. [DOI: 10.1126/scisignal.aai8529] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
8 Zhu S, Liu M, Bennett S, Wang Z, Pfleger KDG, Xu J. The molecular structure and role of CCL2 (MCP-1) and C-C chemokine receptor CCR2 in skeletal biology and diseases. J Cell Physiol 2021;236:7211-22. [PMID: 33782965 DOI: 10.1002/jcp.30375] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Königshausen E, Zierhut UM, Ruetze M, Potthoff SA, Stegbauer J, Woznowski M, Quack I, Rump LC, Sellin L. Angiotensin II increases glomerular permeability by β-arrestin mediated nephrin endocytosis. Sci Rep 2016;6:39513. [PMID: 28004760 DOI: 10.1038/srep39513] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
10 Turu G, Balla A, Hunyady L. The Role of β-Arrestin Proteins in Organization of Signaling and Regulation of the AT1 Angiotensin Receptor. Front Endocrinol (Lausanne) 2019;10:519. [PMID: 31447777 DOI: 10.3389/fendo.2019.00519] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
11 Sanchez J, E Huma Z, Lane JR, Liu X, Bridgford JL, Payne RJ, Canals M, Stone MJ. Evaluation and extension of the two-site, two-step model for binding and activation of the chemokine receptor CCR1. J Biol Chem 2019;294:3464-75. [PMID: 30567735 DOI: 10.1074/jbc.RA118.006535] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
12 Ayoub MA, Landomiel F, Gallay N, Jégot G, Poupon A, Crépieux P, Reiter E. Assessing Gonadotropin Receptor Function by Resonance Energy Transfer-Based Assays. Front Endocrinol (Lausanne) 2015;6:130. [PMID: 26379624 DOI: 10.3389/fendo.2015.00130] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
13 Forrester SJ, Booz GW, Sigmund CD, Coffman TM, Kawai T, Rizzo V, Scalia R, Eguchi S. Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology. Physiol Rev 2018;98:1627-738. [PMID: 29873596 DOI: 10.1152/physrev.00038.2017] [Cited by in Crossref: 280] [Cited by in F6Publishing: 260] [Article Influence: 70.0] [Reference Citation Analysis]
14 Jonas K, Hanyaloglu A. Impact of G protein-coupled receptor heteromers in endocrine systems. Molecular and Cellular Endocrinology 2017;449:21-7. [DOI: 10.1016/j.mce.2017.01.030] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
15 de Zeeuw D, Bekker P, Henkel E, Hasslacher C, Gouni-Berthold I, Mehling H, Potarca A, Tesar V, Heerspink HJ, Schall TJ. The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial. Lancet Diabetes Endocrinol. 2015;3:687-696. [PMID: 26268910 DOI: 10.1016/s2213-8587(15)00261-2] [Cited by in Crossref: 172] [Cited by in F6Publishing: 104] [Article Influence: 24.6] [Reference Citation Analysis]
16 Sengupta D, Kumar GA, Chattopadhyay A. Interaction of Membrane Cholesterol with GPCRs: Implications in Receptor Oligomerization. In: Herrick-davis K, Milligan G, Di Giovanni G, editors. G-Protein-Coupled Receptor Dimers. Cham: Springer International Publishing; 2017. pp. 415-29. [DOI: 10.1007/978-3-319-60174-8_16] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
17 Tóth AD, Turu G, Hunyady L, Balla A. Novel mechanisms of G-protein-coupled receptors functions: AT1 angiotensin receptor acts as a signaling hub and focal point of receptor cross-talk. Best Pract Res Clin Endocrinol Metab 2018;32:69-82. [PMID: 29678287 DOI: 10.1016/j.beem.2018.02.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
18 Quagliariello V, Bonelli A, Caronna A, Conforti G, Iovine M, Carbone A, Berretta M, Botti G, Maurea N. SARS-CoV-2 Infection and Cardioncology: From Cardiometabolic Risk Factors to Outcomes in Cancer Patients. Cancers (Basel) 2020;12:E3316. [PMID: 33182653 DOI: 10.3390/cancers12113316] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
19 Jacobson KA. New paradigms in GPCR drug discovery. Biochem Pharmacol 2015;98:541-55. [PMID: 26265138 DOI: 10.1016/j.bcp.2015.08.085] [Cited by in Crossref: 112] [Cited by in F6Publishing: 99] [Article Influence: 16.0] [Reference Citation Analysis]
20 Lim HD, Lane JR, Canals M, Stone MJ. Systematic Assessment of Chemokine Signaling at Chemokine Receptors CCR4, CCR7 and CCR10. Int J Mol Sci 2021;22:4232. [PMID: 33921794 DOI: 10.3390/ijms22084232] [Reference Citation Analysis]
21 Rukavina Mikusic NL, Silva MG, Pineda AM, Gironacci MM. Angiotensin Receptors Heterodimerization and Trafficking: How Much Do They Influence Their Biological Function? Front Pharmacol 2020;11:1179. [PMID: 32848782 DOI: 10.3389/fphar.2020.01179] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
22 Johnstone EKM, Pfleger KDG. Profiling novel pharmacology of receptor complexes using Receptor-HIT. Biochem Soc Trans 2021;49:1555-65. [PMID: 34436548 DOI: 10.1042/BST20201110] [Reference Citation Analysis]
23 Gomes I, Ayoub MA, Fujita W, Jaeger WC, Pfleger KD, Devi LA. G Protein-Coupled Receptor Heteromers. Annu Rev Pharmacol Toxicol 2016;56:403-25. [PMID: 26514203 DOI: 10.1146/annurev-pharmtox-011613-135952] [Cited by in Crossref: 168] [Cited by in F6Publishing: 140] [Article Influence: 24.0] [Reference Citation Analysis]
24 Crowley SD, Rudemiller NP. Immunologic Effects of the Renin-Angiotensin System. J Am Soc Nephrol 2017;28:1350-61. [PMID: 28151411 DOI: 10.1681/ASN.2016101066] [Cited by in Crossref: 65] [Cited by in F6Publishing: 52] [Article Influence: 13.0] [Reference Citation Analysis]
25 Johnstone EKM, Ayoub MA, Hertzman RJ, See HB, Abhayawardana RS, Seeber RM, Pfleger KDG. Novel Pharmacology Following Heteromerization of the Angiotensin II Type 2 Receptor and the Bradykinin Type 2 Receptor. Front Endocrinol (Lausanne) 2022;13:848816. [PMID: 35721749 DOI: 10.3389/fendo.2022.848816] [Reference Citation Analysis]
26 Kuroda Y, Nonaka M, Kamikubo Y, Ogawa H, Murayama T, Kurebayashi N, Sakairi H, Miyano K, Komatsu A, Dodo T, Nakano-Ito K, Yamaguchi K, Sakurai T, Iseki M, Hayashida M, Uezono Y. Inhibition of endothelin A receptor by a novel, selective receptor antagonist enhances morphine-induced analgesia: Possible functional interaction of dimerized endothelin A and μ-opioid receptors. Biomed Pharmacother 2021;141:111800. [PMID: 34175819 DOI: 10.1016/j.biopha.2021.111800] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Johnstone EKM, See HB, Abhayawardana RS, Song A, Rosengren KJ, Hill SJ, Pfleger KDG. Investigation of Receptor Heteromers Using NanoBRET Ligand Binding. Int J Mol Sci 2021;22:1082. [PMID: 33499147 DOI: 10.3390/ijms22031082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Ayoub MA. Angiotensin II type 1 receptor heterodimers in the kidney. Current Opinion in Endocrine and Metabolic Research 2021;16:96-101. [DOI: 10.1016/j.coemr.2020.09.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Kiriakidi S, Kolocouris A, Liapakis G, Ikram S, Durdagi S, Mavromoustakos T. Effects of Cholesterol on GPCR Function: Insights from Computational and Experimental Studies. In: Rosenhouse-dantsker A, Bukiya AN, editors. Direct Mechanisms in Cholesterol Modulation of Protein Function. Cham: Springer International Publishing; 2019. pp. 89-103. [DOI: 10.1007/978-3-030-14265-0_5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
30 Zamel IA, Palakkott A, Ashraf A, Iratni R, Ayoub MA. Interplay Between Angiotensin II Type 1 Receptor and Thrombin Receptor Revealed by Bioluminescence Resonance Energy Transfer Assay. Front Pharmacol 2020;11:1283. [PMID: 32973514 DOI: 10.3389/fphar.2020.01283] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
31 Miao Z, Ertl LS, Newland D, Zhao B, Wang Y, Zang X, Campbell JJ, Liu X, Dang T, Miao S, Krasinski A, Punna S, Zeng Y, McMahon J, Zhang P, Charo IF, Schall TJ, Singh R. CCR2 antagonism leads to marked reduction in proteinuria and glomerular injury in murine models of focal segmental glomerulosclerosis (FSGS). PLoS One 2018;13:e0192405. [PMID: 29561839 DOI: 10.1371/journal.pone.0192405] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]